164 related articles for article (PubMed ID: 30661578)
1. Integrated analyses utilizing metabolomics and transcriptomics reveal perturbation of the polyamine pathway in oral cavity squamous cell carcinoma.
Hsu CW; Chen YT; Hsieh YJ; Chang KP; Hsueh PC; Chen TW; Yu JS; Chang YS; Li L; Wu CC
Anal Chim Acta; 2019 Mar; 1050():113-122. PubMed ID: 30661578
[TBL] [Abstract][Full Text] [Related]
2. ¹H NMR-derived serum metabolomics of leukoplakia and squamous cell carcinoma.
Gupta A; Gupta S; Mahdi AA
Clin Chim Acta; 2015 Feb; 441():47-55. PubMed ID: 25499120
[TBL] [Abstract][Full Text] [Related]
3. Serum metabolomics in oral leukoplakia and oral squamous cell carcinoma.
Sridharan G; Ramani P; Patankar S
J Cancer Res Ther; 2017; 13(3):556-561. PubMed ID: 28862226
[TBL] [Abstract][Full Text] [Related]
4. Salivary metabolite signatures of oral cancer and leukoplakia.
Wei J; Xie G; Zhou Z; Shi P; Qiu Y; Zheng X; Chen T; Su M; Zhao A; Jia W
Int J Cancer; 2011 Nov; 129(9):2207-17. PubMed ID: 21190195
[TBL] [Abstract][Full Text] [Related]
5. Secretome profiling of primary cells reveals that THBS2 is a salivary biomarker of oral cavity squamous cell carcinoma.
Hsu CW; Yu JS; Peng PH; Liu SC; Chang YS; Chang KP; Wu CC
J Proteome Res; 2014 Nov; 13(11):4796-807. PubMed ID: 24708169
[TBL] [Abstract][Full Text] [Related]
6. Integration of transcriptomics and metabolomics reveals a novel gene signature guided by FN1 associated with immune response in oral squamous cell carcinoma tumorigenesis.
Peng Y; Yin D; Li X; Wang K; Li W; Huang Y; Liu X; Ren Z; Yang X; Zhang Z; Zhang S; Fan T
J Cancer Res Clin Oncol; 2023 Aug; 149(9):6097-6113. PubMed ID: 36656379
[TBL] [Abstract][Full Text] [Related]
7. Malignancy prediction among tissues from Oral SCC patients including neck invasions: a
Paul A; Srivastava S; Roy R; Anand A; Gaurav K; Husain N; Jain S; Sonkar AA
Metabolomics; 2020 Mar; 16(3):38. PubMed ID: 32162079
[TBL] [Abstract][Full Text] [Related]
8. SCCA, TSGF, and the Long Non-Coding RNA AC007271.3 are Effective Biomarkers for Diagnosing Oral Squamous Cell Carcinoma.
Shao T; Huang J; Zheng Z; Wu Q; Liu T; Lv X
Cell Physiol Biochem; 2018; 47(1):26-38. PubMed ID: 29763905
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of caldesmon is associated with lymph node metastasis and poorer prognosis in patients with oral cavity squamous cell carcinoma.
Chang KP; Wang CL; Kao HK; Liang Y; Liu SC; Huang LL; Hseuh C; Hsieh YJ; Chien KY; Chang YS; Yu JS; Chi LM
Cancer; 2013 Nov; 119(22):4003-11. PubMed ID: 23963810
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-155 in oral squamous cell carcinoma: Overexpression, localization, and prognostic potential.
Shi LJ; Zhang CY; Zhou ZT; Ma JY; Liu Y; Bao ZX; Jiang WW
Head Neck; 2015 Jul; 37(7):970-6. PubMed ID: 24692283
[TBL] [Abstract][Full Text] [Related]
11. Notch Signaling Activation Is Associated with Patient Mortality and Increased FGF1-Mediated Invasion in Squamous Cell Carcinoma of the Oral Cavity.
Weaver AN; Burch MB; Cooper TS; Della Manna DL; Wei S; Ojesina AI; Rosenthal EL; Yang ES
Mol Cancer Res; 2016 Sep; 14(9):883-91. PubMed ID: 27353029
[TBL] [Abstract][Full Text] [Related]
12. Salivary extracellular vesicle-associated miRNAs as potential biomarkers in oral squamous cell carcinoma.
Gai C; Camussi F; Broccoletti R; Gambino A; Cabras M; Molinaro L; Carossa S; Camussi G; Arduino PG
BMC Cancer; 2018 Apr; 18(1):439. PubMed ID: 29669525
[TBL] [Abstract][Full Text] [Related]
13. Exploring a Novel Screening Method for Patients with Oral Squamous Cell Carcinoma: A plasma Metabolomics Analysis.
Enomoto Y; Kimoto A; Suzuki H; Nishiumi S; Yoshida M; Komori T
Kobe J Med Sci; 2018 Sep; 64(1):E26-E35. PubMed ID: 30282895
[TBL] [Abstract][Full Text] [Related]
14. miR-654-5p Targets GRAP to Promote Proliferation, Metastasis, and Chemoresistance of Oral Squamous Cell Carcinoma Through Ras/MAPK Signaling.
Lu M; Wang C; Chen W; Mao C; Wang J
DNA Cell Biol; 2018 Apr; 37(4):381-388. PubMed ID: 29364705
[TBL] [Abstract][Full Text] [Related]
15. Metabolic landscape of oral squamous cell carcinoma.
Vitório JG; Duarte-Andrade FF; Dos Santos Fontes Pereira T; Fonseca FP; Amorim LSD; Martins-Chaves RR; Gomes CC; Canuto GAB; Gomez RS
Metabolomics; 2020 Sep; 16(10):105. PubMed ID: 33000429
[TBL] [Abstract][Full Text] [Related]
16. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
Su L; Wang Y; Xiao M; Lin Y; Yu L
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
[TBL] [Abstract][Full Text] [Related]
17. Measurement of salivary metabolite biomarkers for early monitoring of oral cancer with ultra performance liquid chromatography-mass spectrometry.
Wang Q; Gao P; Cheng F; Wang X; Duan Y
Talanta; 2014 Feb; 119():299-305. PubMed ID: 24401418
[TBL] [Abstract][Full Text] [Related]
18. Parathyroid hormone-related protein serves as a prognostic indicator in oral squamous cell carcinoma.
Lv Z; Wu X; Cao W; Shen Z; Wang L; Xie F; Zhang J; Ji T; Yan M; Chen W
J Exp Clin Cancer Res; 2014 Dec; 33(1):100. PubMed ID: 25539663
[TBL] [Abstract][Full Text] [Related]
19. Interleukin 6 and interleukin 8 as potential biomarkers for oral cavity and oropharyngeal squamous cell carcinoma.
St John MA; Li Y; Zhou X; Denny P; Ho CM; Montemagno C; Shi W; Qi F; Wu B; Sinha U; Jordan R; Wolinsky L; Park NH; Liu H; Abemayor E; Wong DT
Arch Otolaryngol Head Neck Surg; 2004 Aug; 130(8):929-35. PubMed ID: 15313862
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
